Email
Website
Title
OUTLINE
SEARCH RESULTS:
1. Using epidemiological data to assess vascular risk
2. Agenda
3. Identification of CV disease risk factors
4. Identification of CV disease risk factors
5. From risk factors to risk estimation (prognostic models)
6. From risk factors to risk estimation – primary CV prevention setting
7. From risk factors to risk estimation – primary CV prevention setting
8. From risk factors to risk estimation – primary CV prevention setting
9. Risk estimation in low-incidence populations
10. 10-year risk estimation in low-incidence populations
11. 20-year risk estimation in low-incidence populations
12. From risk factors to risk estimation – primary CV prevention setting
13. Calibration – overall survival and risk factors distribution
14. Calibration – overall survival and risk factors distribution
15. Calibration – risk factors effect
16. Recalibration issues – overall survival and risk factors distribution
17. Clinical utility in risk stratification – agreement between risk scores
18. Clinical utility in risk stratification – agreement between risk scores
19. Clinical utility in risk stratification – some measures and definitions
20. Clinical utility in risk stratification – some measures and definitions
21. Risk thresholds for the CAMUNI 20-yr risk score
22. Risk thresholds for the CAMUNI 20-yr risk score - men
23. Risk thresholds for the CAMUNI 20-yr risk score - women
24. External validity of risk prediction models
25. Improvement in CV risk stratification
26. Improvement in CV risk stratification
27. Improvement by addition – criteria and metrics
28. Improvement by addition – circulating biomarkers
29. Improvement by addition – circulating biomarkers
30. Improvement by addition – metrics criticized
31. Improvement in CVD risk stratification
32. Improvement by replacement – the Apolipoprotein A case
33. Improvement by replacement – the Apolipoprotein A case
34. Improvement by replacement – the Apolipoprotein A case
35. Improvement by replacement – the Apolipoprotein A case
36. Improvement in CVD risk stratification
37. Improvement in CVD risk stratification
38. Improvement in CVD risk stratification
39. Clinical utility assessment - low short term risk
40. Clinical utility assessment – low short-term risk
41. Take-home messages
42. Take-home messages
43. Work in progress
44. Risk Of Cardiovascular diseases and abdominal aortic Aneurism in Varese
45. Work in progress
46. Work in progress
47. Thanks for your attention!